March 18, 2019 Bio/Pharma/CRO Clinical Research/Diagn. Environ, Ag./Food & Bev Informatics & Software Lab Top-10 Mass Spectrometry Molecular Spectroscopy Product Launch

Bruker Highlights New Systems and Applied Market Solutions at Pittcon

PHILADELPHIA, March 18, 2019 /PRNewswire/ — At Pittcon 2019, Bruker (Nasdaq: BRKR) this week highlights new and innovative analytical systems and high-value applied market solutions for food analysis, pharma applications, materials science research and quality control, clinical and preclinical research, and advances in scientific software solutions. Frank H. Laukien, Ph.D., Bruker’s President and CEO, commented:  “Our... Read more

March 14, 2019 Bio/Pharma/CRO Clinical Research/Diagn. Product Launch

Lonza Expands Mycoplasma Detection Portfolio with New Luminometer Designed to Accelerate and Simplify Testing

Walkersville, MD (USA) / Basel, Switzerland, 14 March 2019 – Lonza has further strengthened its extensive mycoplasma detection portfolio with the addition of the Lucetta™ 2 Luminometer, a single-tube system designed to simplify and accelerate mycoplasma detection in cell cultures. Pharmaceutical, biotechnology and academic researchers can now rely on this compact, portable and easy-to-use instrument to... Read more

March 14, 2019 Acad, Gov/Utilities Bio/Pharma/CRO PR/Corporate

BD Receives U.S. FDA Approval for First Venous Stent to Treat Iliofemoral Venous Occlusive Disease

FRANKLIN LAKES, N.J., March 14, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration has granted premarket approval for the Venovo™ venous stent, the first stent indicated to treat iliofemoral venous occlusive disease, which is obstructed or narrowed blood flow specific to... Read more

March 7, 2019 Bio/Pharma/CRO Life Science Tools Product Launch

Nuvec®: A breakthrough technology for mRNA / pDNA delivery for vaccines and cancer treatments

N4 Pharma Plc (AIM: N4P), a specialist pharmaceutical company, is developing Nuvec® – a unique non-viral adjuvant delivery system for vaccines and cancer treatments. This silica nanoparticle has the potential to help commercialize cancer immunotherapy drugs and improve the effectiveness of viral vaccines. Nuvec® silica nanoparticles have a unique irregular (spikey) surface structure, coupled with... Read more

February 25, 2019 Bio/Pharma/CRO Lab Top-10 Product Launch

Thermo Fisher Scientific Launches New Dosimetry Monitoring Service

Medical and dental facilities, nuclear power plants and other sites can now simplify their radiation safety program by accessing dosimetry technology and services from single provider TEWKSBURY, Mass., Feb. 25, 2019 /PRNewswire/ — A new dosimetry monitoring service from Thermo Fisher Scientific enables medical and imaging facilities, dental offices, veterinary clinics, nuclear power plants, laboratories and... Read more

February 21, 2019 Bio/Pharma/CRO Cell Analysis Tools Product Launch

Releasable antibodies for label-free cells

Multicolor flow cytometry-based cell sorting is the method of choice for isolating specific cell subsets. However, downstream applications using isolated cells are often limited since fluorescence channels and epitopes are blocked by the antibody-fluorochrome conjugates utilized for the flow sorting process. Miltenyi Biotec’s REAlease® Releasable Antibodies with the REAlease Fluorochrome Technology can be removed from... Read more

February 6, 2019 Bio/Pharma/CRO Lab Top-10 PR/Corporate

Merck KGaA, Darmstadt, Germany to Expand US Biopharmaceutical R&D Facility to Advance Innovative Clinical Pipeline

BILLERICA, Mass., February 6, 2019 — Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono in the U.S. and Canada, today announced a $70 million investment to expand its state of the art research and development (R&D) facility in Billerica, Massachusetts. The new building will span 145,000 square feet, offering new laboratory... Read more

January 31, 2019 Bio/Pharma/CRO M&A, Partnerships

Sartorius joins the community of the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

Göttingen, Germany – January 31, 2019: Sartorius, a leading international partner of biopharmaceutical research and the industry, is pleased to announce that it has joined NIIMBL, the National Institute for Innovation in Manufacturing Biopharmaceuticals headquartered in Newark, Delaware, USA. The Institute, launched in 2017, is a public-private partnership and has an extensive network of academic and... Read more

January 30, 2019 Bio/Pharma/CRO Clinical Research/Diagn.

Roche to discontinue Phase III CREAD 1 and 2 clinical studies of crenezumab in early Alzheimer’s disease (AD) – other company programmes in AD continue

Basel, 30 January 2019 Roche to discontinue Phase III CREAD 1 and 2 clinical studies of crenezumab in early Alzheimer’s disease (AD) – other company programmes in AD continue The Alzheimer’s Prevention Initiative (API) study of crenezumab in familial Alzheimer’s disease continues Roche remains committed to ongoing clinical studies in Alzheimer’s disease, including GRADUATE Phase... Read more

January 24, 2019 Bio/Pharma/CRO Clinical Research/Diagn. Informatics & Software Life Science Tools M&A, Partnerships Product Launch

1CellBio and Partek Deliver Easy-to-use Single Cell Analysis Solution

Powerful Single Cell Bioinformatics Solution in a Graphical User Interface Powerful Single Cell Bioinformatics Solution in a Graphical User Interface ST. LOUIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)–1CellBio Inc. and Partek Incorporated have partnered to deliver a data analysis pipeline for the inDrop™ System for use within Partek® Flow® bioinformatics software. The pipeline allows users to pre-process raw inDrop single cell RNA-Seq data and utilize... Read more